Posted on September 12, 2014 by Sitemaster
According to a newly published study of data from > 285,000 European males (the Metabolic Syndrome and Cancer Project), men with metabolic aberrations are at slightly less risk for a diagnosis of prostate cancer compared with men who have normal levels of metabolic factors … but their risk for prostate cancer-specific mortality is similar. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: aberrant, BMI, body mass index, Diagnosis, metabolic, mortality, risk | Leave a comment »
Posted on November 5, 2010 by Sitemaster
Grace Lu-Yao and colleagues have posted an interesting “Beyond the Abstract” commentary on the UroToday web site in relation to recent data about the associations between obesity and prostate cancer in America. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, BMI, body mass index, obesity, risk | 2 Comments »
Posted on October 1, 2009 by Sitemaster
In today’s news reports we cover items on:
- Risks for prostate cancer from smoking and increased adipose tissue
- The role of religious activities in prostate cancer testing among African Americans
- Blood loss at the time of surgery and risk for progressive disease … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: adipose, blood loss, BMI, body mass index, DRE, ethnicity, recurrence, religion, risk, smoking | Leave a comment »
Posted on July 21, 2009 by Sitemaster
In today’s news reports we comment on studies dealing with:
- PSA level, body mass index, risk, and outcomes
- External beam radiotherapy in treatment of Japanese patients
- An endorectal balloon to prevent anal/rectal side effects of radiation?
- The optimal period of neoadjuvant hormone therapy prior to radiation therapy … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BMI, body mass index, EBRT, endorectal balloon, external beam radiation, neoadjuvant hormone therapy, obesity, PSA | Leave a comment »
Posted on December 26, 2008 by Sitemaster
With at least a dozen new reports available today, we have chosen to focus only on the most significant, several of which may be of clinical importance now or in the near future. Most of the other items provide minimal new information and can be accessed through the UroToday web site by those who are interested. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BMI, body mass index, dexamethasone, docetaxel, genetic testing, genetics, laparoscopic surgery, LRP, prior malignancies, RALP | Leave a comment »
